NCBIO Roadmap to Diversity Event
“Our workforces are more dynamic. They're more empowered, they're more enlightened, and they want answers not just from the standpoint of their functional skills and capabilities in our business performance. But also what is it that our company stands for?” -- Keynote speaker Celeste Warren, VP, Merck Global Diversity and Inclusion Center
NCBIO Members Save Big with BIO Business Solutions
BIO Business Solutions offers NCBIO members the opportunity to pool their purchasing power with other life science companies nationwide to command significant discounts for frequently used products and services.
NCBIO, the North Carolina Biosciences Organization
NCBIO is the trade association for North Carolina’s life science industry. Members include companies and research institutions working in the pharmaceutical, medical device, diagnostic, clinical research and agricultural biotechnology sectors, as well as firms and nonprofits that provide support services to life science companies. Founded in 1994, NCBIO works to help North Carolina’s life sciences community fulfill its extraordinary promise as a source of economic opportunity and improved quality of life through effective advocacy and policy.
Partners and Resources
NCBIO works with national organizations and connects with many North Carolina life science resources.
Collaboration and statewide support make North Carolina a thriving hub of urgently needed innovation in rare disease.
The rarest day on the calendar is the one that does not even occur in every year: February 29. In 2008, this was designated as Rare Disease Day and since then, the last day of February has been an opportunity to draw attention to, honor and support people living with these conditions.Read More
Where things stand with the TRIPS waiver
The World Trade Organization is considering continuing to waive certain intellectual property rights on COVID-19 diagnostics and therapeutics, following a recent decision to do the same for vaccines.Read More
Expanding COVID IP waiver would harm small, medium enterprises, CSBA says
Every member of the Council of State Bioscience Associations signed a letter to President Joe Biden expressing serious concerns with the proposed expansion of IP protections for COVID technology.Read More
Part D drug price “negotiation” comes at cost of jobs, investment, cures
Congress passed the Inflation Reduction Act on Aug. 12. Included in the law is a provision that gives Medicare Part D the ability to “negotiate” the price of medicines for the first time. Negotiate is in quotation marks because lawmakers are being ironic; no one can legitimately call the new price-setting policy a negotiation.Read More
Medical Device Forum panel discusses regulatory, supply chain challenges
“Navigating Regulatory and Supply Chain Challenges Today and Tomorrow” was the topic of the May 16 NCBIO Medical Device Luncheon and Forum held at the N.C Biotechnology Center.
The discussion was moderated by Eric Hill, senior director, scientific and technical services for Boston Analytical. The event was sponsored by Clancy & Theys Construction Company, Hughes Pittman & Gupton, Mercury Business Services, UniClean Cleanroom Services and YourBio Health.
To start off, the panelists gave an overview of what was currently happening and most relevant to them in their working environment.Read More
Panelists offer advice on funding options for emerging companies
Panelists at the NCBIO Emerging Companies Luncheon and Forum held Wednesday, March 22, at the NC Biotechnology Center offering insight into the way their organizations choose investments, when to seek SBIR funding, engaging with a funding agency for the first time and more.
The forum was sponsored by Clancy & Theys Construction Company, JBK Associates International, Nikon and SAS.
The panel was moderated by Kseniya Simpson, Ph.D., associate, Hatteras Venture Partners.Read More
BMF meeting explores $25 million Build Back Better grant projects
At the March 15 meeting the NCBIO Biomanufacturers Forum, attendees received updates on the $25 million Build Back Better Regional Challenge grant awarded in the fall. In September, a statewide coalition of public and private partner organizations and institutions led by NC Biotech and including NCBIO received the award from the U.S. Economic Development Administration’s Build Back Better Regional Challenge. The grant will support a number of life sciences workforce initiatives collectively called Accelerate NC.Read More
Photo Gallery: 2023 Legislative Reception
Approximately 300 NCBIO member representatives and North Carolina law makers came together Wednesday, March 1, at the NCBIO Legislative Reception held at the NC Museum of History in Raleigh.Read More